AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids


You May Also Like

Moleculin Announces Enrollment Opens for Brain Tumor Trial of WP1066

HOUSTON, July 31, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or ...

Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch

BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix® announced a new collaboration agreement ...